As almost all human cancers carry abnormalities in the pRB/E2F pathway components including INK4A, CCND, CDK4/6, RB1, or E2Fs, genetic of functional inactivation of the pRB/E2F pathway seems to be indispensable for deregulated proliferation in most cancer settings [107]. The gene discussed is RB1; the disease is cancer.